NCT04664569
- Conditions
- Antibiotic Treatment, Case Fatality Rate, Children, Only, +7 more
- Locations
-
- ACTIV Créteil, France
Clinical trial condition
Meningococcal Vaccines
Explore clinical trials studying Meningococcal Vaccines. Study availability and eligibility vary by location and protocol.
13 public trials
1 recruiting study
Meningococcal Vaccines trial results
Not Yet Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
NCT07505823
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NCT07505836
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years
NCT07505888
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
- Locations
-
Not specified
NCT05873751
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia, +12 more
- Locations
-
- Pfizer New York, United States
NCT02398396
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Factor H-binding Protein, Neisseria Meningitidi, +6 more
- Locations
-
- Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom
NCT02810340
- Conditions
- Meningococcal Vaccines
- Locations
-
- Center for Vaccine Development Baltimore, Maryland, United States
NCT01144663
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Haabneeme, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
NCT01266993
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Draguignan, France
- GSK Investigational Site Le Havre, France
- GSK Investigational Site Lingolsheim, France
- GSK Investigational Site Miribel, France